Related Experiment Video
Updated: Oct 25, 2026

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Intelligent exogenous predictive networks for nonlinear Parkinson's disease model involving delay with effects of
Naveed Ishtiaq Chaudhary1, Aqib Mukhtar2, Iqra I Chaudhary3
1Graduate School of Intelligent Data Science, National Yunlin University of Science and Technology, Yunlin, 64002, Taiwan.
Abstract:
Artificial intelligence is used to simulate, solve, or approximate the dynamics of complex neurodegenerative diseases through accurate prediction. Parkinson's disease (PD) is a progressive disorder caused by the loss of dopaminergic neurons, leading to motor impairments such as muscle stiffness, tremors, and Bradykinesia. In this study, artificial intelligence-driven nonlinear autoregressive exogenous neural networks (AI-NARX-NN) are applied to the existing mathematical model reflecting the dynamics of innate as well as adaptive immune responses to PD under immunotherapy (IAIR-PDI). The IAIR-PDI model is characterized by a delay differential system of five classes representing the densities of healthy neurons, affected neurons, extracellular alpha-syn, activated microglia, and activated T cells. The performance of the AI-NARX-NN is investigated in scenarios of active immunization, passive immunization, and no treatment in the IAIR-PDI model. In the active immunization case, short antigenic peptide vaccination is given to the patients that mimics alpha-syn to generate antibodies, whereas in the passive immunization case, antibody vaccination is given directly to PD patients. The simulation results, including mean-square-error-based convergence curves, histograms, error correlation, solution plots, and corresponding absolute errors, confirm strong agreement between the AI-NARX-NN predictions and the reference numerical solutions, supporting the accuracy of the proposed scheme for the IAIR-PDI model with different time delays.
Related Concept Videos
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease ll: Pathophysiology
Neural Regulation
Parkinson Disease l: Introduction
Pharmacodynamic Models: Additive and Proportional Drug Effect Model
EPS and iPS Cells in Disease Research
